Page 1 of 1

Aubagio (teriflunomide) and Tecfidera (BG-12) move closer

Posted: Fri Mar 22, 2013 8:58 am
by MSUK
Aubagio (teriflunomide) and Tecfidera (BG-12) move closer to European approval

The Committee for Medicinal Products for Human Use (CHMP) issued positive opinions on two new MS therapies. Recommending the granting of a marketing authorisation for the medicinal product Tecfidera 120 mg and 240 mg, gastro-resistant hard capsules, intended for the treatment of adult patients with relapsing remitting multiple sclerosis and Aubagio 14 mg film-coated tablet intended for the treatment of multiple sclerosis.... Read More - http://www.ms-uk.org/index.cfm/MSnews